$SRNE At the beginning of the year SRNE had no COVID pipeline. They have diversified their portfolio by leveraging their MAB library . Today I saw the true color of the longs who were quick to accuse the company and become naysayers and shorties. Instead think that they gave us more pipelines and are finding more use for their existing products. Remain hopeful. I admire Henry for putting together this presentation knowing fully well this could affect his compensation package. Just days from their board meeting.